GSA Capital Partners LLP Makes New $933,000 Investment in Encompass Health Corporation $EHC

Key Points

• GSA Capital Partners acquired 9,234 Encompass Health shares worth approximately $933,000 during the second quarter. Institutional investors collectively own 97.25% of the company.
• Encompass Health beat quarterly expectations, reporting $1.55 in EPS versus the $1.48 consensus and $1.60 billion in revenue, up 9.6% year over year. Analysts maintain a consensus “Buy” rating with an average price target of $148.71.
• The company raised its quarterly dividend from $0.19 to $0.21 per share, implying an annualized dividend of $0.84 and a 0.7% yield; meanwhile, the CEO and an executive vice president sold shares in August.

GSA Capital Partners LLP acquired a new stake in Encompass Health Corporation (NYSE:EHC - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 9,234 shares of the company's stock, valued at approximately $933,000.

Other hedge funds have also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. boosted its stake in Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company's stock worth $402,640,000 after purchasing an additional 3,793,358 shares during the period. AlphaCore Capital LLC bought a new stake in shares of Encompass Health during the fourth quarter valued at approximately $4,881,000. Systematic Financial Management LP lifted its holdings in shares of Encompass Health by 3.6% in the fourth quarter. Systematic Financial Management LP now owns 440,752 shares of the company's stock worth $46,782,000 after buying an additional 15,462 shares in the last quarter. Asset Management One Co. Ltd. boosted its position in shares of Encompass Health by 128.7% during the fourth quarter. Asset Management One Co. Ltd. now owns 129,205 shares of the company's stock worth $13,790,000 after acquiring an additional 72,703 shares during the last quarter. Finally, Trillium Asset Management LLC grew its stake in Encompass Health by 5.7% during the fourth quarter. Trillium Asset Management LLC now owns 217,734 shares of the company's stock valued at $23,424,000 after acquiring an additional 11,793 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Encompass Health Price Performance

Encompass Health stock opened at $122.35 on Wednesday. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm's fifty day moving average is $109.89 and its 200 day moving average is $105.91. The company has a market cap of $12.07 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 2.51 and a beta of 0.72.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The business's revenue was up 9.6% on a year-over-year basis. During the same period last year, the company posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Sell-side analysts forecast that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, October 1st. This is an increase from Encompass Health's previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health's payout ratio is presently 12.38%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on EHC. UBS Group lifted their price target on shares of Encompass Health from $150.00 to $155.00 and gave the company a "buy" rating in a report on Friday, August 7th. Truist Financial increased their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, August 7th. Wall Street Zen raised Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday. Leerink Partners set a $152.00 target price on Encompass Health in a research report on Friday, May 22nd. Finally, Barclays increased their price target on Encompass Health from $140.00 to $144.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $148.71.

Insider Activity at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 173,148 shares of the company's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP John Patrick Darby sold 8,906 shares of the firm's stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the sale, the executive vice president directly owned 75,041 shares of the company's stock, valued at $9,451,413.95. The trade was a 10.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.80% of the company's stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source